Blood marker may predict deadly bleeding in Life-Support patients
NCT ID NCT07039513
First seen Dec 08, 2025 · Last updated Jun 07, 2026 · Updated 25 times
Summary
This study will follow 100 intensive care patients on ECMO (a heart-lung machine) to see if changes in a blood marker called D-dimer can predict serious bleeding within 24 hours. Bleeding is a major risk for these patients, and finding a way to forecast it could help doctors act faster. The goal is to identify a clear threshold for D-dimer increase that signals danger.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECMO are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Médecine Intensive - Réanimation Nouvel Hôpital Civil
Strasbourg, 67098, France
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.